Matches in Nanopublications for { ?s ?p "[In conclusion, several mechanisms, including apoptosis-induction, modulation of expression/phosphorylation of RKIP and crucial kinases contribute to erlotinib-sorafenib synergistic interaction and should be evaluated in future trials for the rational development of this combination in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP914650.RAuwaghW25tJD1ySWgGJ99CHQb49VsEWBKVocpx1YCmsY130_assertion description "[In conclusion, several mechanisms, including apoptosis-induction, modulation of expression/phosphorylation of RKIP and crucial kinases contribute to erlotinib-sorafenib synergistic interaction and should be evaluated in future trials for the rational development of this combination in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914650.RAuwaghW25tJD1ySWgGJ99CHQb49VsEWBKVocpx1YCmsY130_provenance.
- NP605252.RAVOe4VfQt8IkK-7rKZ7XJDMmyy8-77qq9saoChFpZa2U130_assertion description "[In conclusion, several mechanisms, including apoptosis-induction, modulation of expression/phosphorylation of RKIP and crucial kinases contribute to erlotinib-sorafenib synergistic interaction and should be evaluated in future trials for the rational development of this combination in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605252.RAVOe4VfQt8IkK-7rKZ7XJDMmyy8-77qq9saoChFpZa2U130_provenance.
- assertion description "[In conclusion, several mechanisms, including apoptosis-induction, modulation of expression/phosphorylation of RKIP and crucial kinases contribute to erlotinib-sorafenib synergistic interaction and should be evaluated in future trials for the rational development of this combination in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1012664.RA1Qc926dnBtGQkK9pWCfaZaOUD-70l1bUKvmRUX63i5I130_assertion description "[In conclusion, several mechanisms, including apoptosis-induction, modulation of expression/phosphorylation of RKIP and crucial kinases contribute to erlotinib-sorafenib synergistic interaction and should be evaluated in future trials for the rational development of this combination in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1012664.RA1Qc926dnBtGQkK9pWCfaZaOUD-70l1bUKvmRUX63i5I130_provenance.